Anavex Life Sciences Corp (AVXL)

[Rubyred77]

How about this:

Can the FDA keep the momentum going for rare disease drug approvals?

While trofinetide, which is being developed by Acadia Pharmaceuticals and Neuren Pharmaceuticals, has a PDUFA date in March, a regulatory decision for Anavex Life Sciences’ blarcamesine hydrochloride is also expected by the year’s end.

https://www.pharmaceutical-technology.com/features/can-the-fda-keep-the-momentum-going-for-rare-disease-drug-approvals/